VizMark Inc. Appoints Chris L. Marsh to Board of Directors
VizMark Inc. has appointed Chris L. Marsh, a veteran CEO and technology executive, to its Board of Directors. Marsh joins the company as it advances its innovative VM-1 breast biopsy marker, the first FDA-cleared non-metallic option in the market.
Veteran CEO, technology executive and investor joins the company behind VM-1, the first FDA-cleared non-metallic breast biopsy marker.
MINNEAPOLIS, MN, UNITED STATES, September 30, 2026 /EINPresswire.com/ — VizMark Inc., a Minnesota-based medical …